nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—coronary artery disease	0.187	1	CbGaD
Fospropofol—ALB—Pitavastatin—coronary artery disease	0.0749	0.19	CbGbCtD
Fospropofol—ALB—Valsartan—coronary artery disease	0.0729	0.185	CbGbCtD
Fospropofol—ALB—Rosuvastatin—coronary artery disease	0.0552	0.14	CbGbCtD
Fospropofol—ALB—Acetylsalicylic acid—coronary artery disease	0.0538	0.136	CbGbCtD
Fospropofol—ALB—Captopril—coronary artery disease	0.0532	0.135	CbGbCtD
Fospropofol—ALB—Furosemide—coronary artery disease	0.0427	0.108	CbGbCtD
Fospropofol—ALB—Losartan—coronary artery disease	0.0418	0.106	CbGbCtD
Fospropofol—Propofol—CYP2C19—coronary artery disease	0.00236	0.643	CrCbGaD
Fospropofol—Propofol—ALB—coronary artery disease	0.00131	0.357	CrCbGaD
Fospropofol—Mediastinal disorder—Ezetimibe—coronary artery disease	0.00108	0.00488	CcSEcCtD
Fospropofol—Angiopathy—Eplerenone—coronary artery disease	0.00106	0.00481	CcSEcCtD
Fospropofol—Hypotension—Ticagrelor—coronary artery disease	0.00106	0.00481	CcSEcCtD
Fospropofol—Mediastinal disorder—Eplerenone—coronary artery disease	0.00105	0.00478	CcSEcCtD
Fospropofol—Paraesthesia—Gemfibrozil—coronary artery disease	0.00104	0.00473	CcSEcCtD
Fospropofol—Headache—Pitavastatin—coronary artery disease	0.00103	0.00466	CcSEcCtD
Fospropofol—Paraesthesia—Ticagrelor—coronary artery disease	0.00102	0.00462	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.001	0.00455	CcSEcCtD
Fospropofol—Nervous system disorder—Rosuvastatin—coronary artery disease	0.001	0.00454	CcSEcCtD
Fospropofol—Pain—Gemfibrozil—coronary artery disease	0.000993	0.0045	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.00098	0.00444	CcSEcCtD
Fospropofol—Angiopathy—Valsartan—coronary artery disease	0.000977	0.00443	CcSEcCtD
Fospropofol—Nausea—Pitavastatin—coronary artery disease	0.000974	0.00441	CcSEcCtD
Fospropofol—Angiopathy—Olmesartan—coronary artery disease	0.000972	0.0044	CcSEcCtD
Fospropofol—Mediastinal disorder—Valsartan—coronary artery disease	0.00097	0.0044	CcSEcCtD
Fospropofol—Mediastinal disorder—Olmesartan—coronary artery disease	0.000965	0.00438	CcSEcCtD
Fospropofol—Angiopathy—Niacin—coronary artery disease	0.00095	0.0043	CcSEcCtD
Fospropofol—Cough—Fenofibrate—coronary artery disease	0.000948	0.0043	CcSEcCtD
Fospropofol—Cough—Clopidogrel—coronary artery disease	0.000932	0.00422	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Fenofibrate—coronary artery disease	0.000918	0.00416	CcSEcCtD
Fospropofol—Paraesthesia—Rosuvastatin—coronary artery disease	0.000917	0.00416	CcSEcCtD
Fospropofol—Cough—Ezetimibe—coronary artery disease	0.000908	0.00411	CcSEcCtD
Fospropofol—Angiopathy—Trandolapril—coronary artery disease	0.000908	0.00411	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Clopidogrel—coronary artery disease	0.000903	0.00409	CcSEcCtD
Fospropofol—Mediastinal disorder—Trandolapril—coronary artery disease	0.000902	0.00409	CcSEcCtD
Fospropofol—Angiopathy—Telmisartan—coronary artery disease	0.000892	0.00404	CcSEcCtD
Fospropofol—Cough—Eplerenone—coronary artery disease	0.000889	0.00403	CcSEcCtD
Fospropofol—Mediastinal disorder—Telmisartan—coronary artery disease	0.000886	0.00401	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—coronary artery disease	0.00088	0.00399	CcSEcCtD
Fospropofol—Pain—Rosuvastatin—coronary artery disease	0.000874	0.00396	CcSEcCtD
Fospropofol—Nervous system disorder—Fenofibrate—coronary artery disease	0.000869	0.00394	CcSEcCtD
Fospropofol—Skin disorder—Fenofibrate—coronary artery disease	0.000861	0.0039	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—coronary artery disease	0.000861	0.0039	CcSEcCtD
Fospropofol—Nervous system disorder—Clopidogrel—coronary artery disease	0.000855	0.00387	CcSEcCtD
Fospropofol—Headache—Penbutolol—coronary artery disease	0.000853	0.00387	CcSEcCtD
Fospropofol—Skin disorder—Clopidogrel—coronary artery disease	0.000847	0.00384	CcSEcCtD
Fospropofol—Angiopathy—Perindopril—coronary artery disease	0.000842	0.00382	CcSEcCtD
Fospropofol—Mediastinal disorder—Perindopril—coronary artery disease	0.000836	0.00379	CcSEcCtD
Fospropofol—Nervous system disorder—Ezetimibe—coronary artery disease	0.000833	0.00377	CcSEcCtD
Fospropofol—Hypotension—Fenofibrate—coronary artery disease	0.000828	0.00375	CcSEcCtD
Fospropofol—Skin disorder—Ezetimibe—coronary artery disease	0.000825	0.00374	CcSEcCtD
Fospropofol—Pruritus—Gemfibrozil—coronary artery disease	0.000822	0.00372	CcSEcCtD
Fospropofol—Angiopathy—Furosemide—coronary artery disease	0.000819	0.00371	CcSEcCtD
Fospropofol—Cough—Valsartan—coronary artery disease	0.000818	0.00371	CcSEcCtD
Fospropofol—Nervous system disorder—Eplerenone—coronary artery disease	0.000815	0.00369	CcSEcCtD
Fospropofol—Hypotension—Clopidogrel—coronary artery disease	0.000814	0.00369	CcSEcCtD
Fospropofol—Cough—Olmesartan—coronary artery disease	0.000814	0.00369	CcSEcCtD
Fospropofol—Nausea—Penbutolol—coronary artery disease	0.000809	0.00367	CcSEcCtD
Fospropofol—Skin disorder—Eplerenone—coronary artery disease	0.000807	0.00366	CcSEcCtD
Fospropofol—Pruritus—Ticagrelor—coronary artery disease	0.000803	0.00364	CcSEcCtD
Fospropofol—Paraesthesia—Fenofibrate—coronary artery disease	0.000796	0.00361	CcSEcCtD
Fospropofol—Cough—Niacin—coronary artery disease	0.000795	0.0036	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.000792	0.00359	CcSEcCtD
Fospropofol—Angiopathy—Losartan—coronary artery disease	0.00079	0.00358	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000788	0.00357	CcSEcCtD
Fospropofol—Cough—Pravastatin—coronary artery disease	0.000783	0.00355	CcSEcCtD
Fospropofol—Paraesthesia—Clopidogrel—coronary artery disease	0.000783	0.00355	CcSEcCtD
Fospropofol—Paraesthesia—Lovastatin—coronary artery disease	0.000777	0.00352	CcSEcCtD
Fospropofol—Hypotension—Eplerenone—coronary artery disease	0.000777	0.00352	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.00077	0.00349	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000765	0.00347	CcSEcCtD
Fospropofol—Paraesthesia—Ezetimibe—coronary artery disease	0.000762	0.00346	CcSEcCtD
Fospropofol—Cough—Trandolapril—coronary artery disease	0.00076	0.00344	CcSEcCtD
Fospropofol—Pain—Fenofibrate—coronary artery disease	0.000758	0.00344	CcSEcCtD
Fospropofol—Cough—Enalapril—coronary artery disease	0.000757	0.00343	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000752	0.00341	CcSEcCtD
Fospropofol—Nervous system disorder—Valsartan—coronary artery disease	0.00075	0.0034	CcSEcCtD
Fospropofol—Cough—Telmisartan—coronary artery disease	0.000747	0.00338	CcSEcCtD
Fospropofol—Nervous system disorder—Olmesartan—coronary artery disease	0.000746	0.00338	CcSEcCtD
Fospropofol—Pain—Clopidogrel—coronary artery disease	0.000745	0.00338	CcSEcCtD
Fospropofol—Skin disorder—Valsartan—coronary artery disease	0.000743	0.00337	CcSEcCtD
Fospropofol—Pain—Lovastatin—coronary artery disease	0.00074	0.00335	CcSEcCtD
Fospropofol—Skin disorder—Olmesartan—coronary artery disease	0.000739	0.00335	CcSEcCtD
Fospropofol—Vomiting—Gemfibrozil—coronary artery disease	0.000739	0.00335	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.000736	0.00334	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000733	0.00332	CcSEcCtD
Fospropofol—Headache—Gemfibrozil—coronary artery disease	0.000728	0.0033	CcSEcCtD
Fospropofol—Paraesthesia—Simvastatin—coronary artery disease	0.000727	0.0033	CcSEcCtD
Fospropofol—Cough—Captopril—coronary artery disease	0.000726	0.00329	CcSEcCtD
Fospropofol—Pain—Ezetimibe—coronary artery disease	0.000726	0.00329	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000724	0.00328	CcSEcCtD
Fospropofol—Pruritus—Rosuvastatin—coronary artery disease	0.000723	0.00328	CcSEcCtD
Fospropofol—Skin disorder—Niacin—coronary artery disease	0.000722	0.00327	CcSEcCtD
Fospropofol—Vomiting—Ticagrelor—coronary artery disease	0.000722	0.00327	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000718	0.00325	CcSEcCtD
Fospropofol—Hypotension—Valsartan—coronary artery disease	0.000715	0.00324	CcSEcCtD
Fospropofol—Hypotension—Olmesartan—coronary artery disease	0.000711	0.00322	CcSEcCtD
Fospropofol—Headache—Ticagrelor—coronary artery disease	0.000711	0.00322	CcSEcCtD
Fospropofol—Pain—Eplerenone—coronary artery disease	0.000711	0.00322	CcSEcCtD
Fospropofol—Cough—Perindopril—coronary artery disease	0.000705	0.00319	CcSEcCtD
Fospropofol—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000702	0.00318	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000699	0.00317	CcSEcCtD
Fospropofol—Nervous system disorder—Trandolapril—coronary artery disease	0.000697	0.00316	CcSEcCtD
Fospropofol—Hypotension—Niacin—coronary artery disease	0.000695	0.00315	CcSEcCtD
Fospropofol—Pain—Simvastatin—coronary artery disease	0.000692	0.00314	CcSEcCtD
Fospropofol—Skin disorder—Trandolapril—coronary artery disease	0.000691	0.00313	CcSEcCtD
Fospropofol—Nausea—Gemfibrozil—coronary artery disease	0.00069	0.00313	CcSEcCtD
Fospropofol—Paraesthesia—Valsartan—coronary artery disease	0.000687	0.00311	CcSEcCtD
Fospropofol—Nervous system disorder—Telmisartan—coronary artery disease	0.000685	0.0031	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000683	0.0031	CcSEcCtD
Fospropofol—Skin disorder—Telmisartan—coronary artery disease	0.000678	0.00307	CcSEcCtD
Fospropofol—Nausea—Ticagrelor—coronary artery disease	0.000674	0.00305	CcSEcCtD
Fospropofol—Mediastinal disorder—Ramipril—coronary artery disease	0.000673	0.00305	CcSEcCtD
Fospropofol—Paraesthesia—Niacin—coronary artery disease	0.000668	0.00303	CcSEcCtD
Fospropofol—Hypotension—Trandolapril—coronary artery disease	0.000664	0.00301	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000664	0.00301	CcSEcCtD
Fospropofol—Angiopathy—Timolol—coronary artery disease	0.000662	0.003	CcSEcCtD
Fospropofol—Hypotension—Enalapril—coronary artery disease	0.000662	0.003	CcSEcCtD
Fospropofol—Cough—Losartan—coronary artery disease	0.000661	0.003	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Valsartan—coronary artery disease	0.00066	0.00299	CcSEcCtD
Fospropofol—Mediastinal disorder—Timolol—coronary artery disease	0.000658	0.00298	CcSEcCtD
Fospropofol—Paraesthesia—Pravastatin—coronary artery disease	0.000657	0.00298	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000657	0.00298	CcSEcCtD
Fospropofol—Hypotension—Telmisartan—coronary artery disease	0.000653	0.00296	CcSEcCtD
Fospropofol—Pain—Olmesartan—coronary artery disease	0.000651	0.00295	CcSEcCtD
Fospropofol—Nervous system disorder—Perindopril—coronary artery disease	0.000647	0.00293	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Niacin—coronary artery disease	0.000642	0.00291	CcSEcCtD
Fospropofol—Skin disorder—Perindopril—coronary artery disease	0.00064	0.0029	CcSEcCtD
Fospropofol—Headache—Rosuvastatin—coronary artery disease	0.00064	0.0029	CcSEcCtD
Fospropofol—Paraesthesia—Trandolapril—coronary artery disease	0.000638	0.00289	CcSEcCtD
Fospropofol—Pain—Niacin—coronary artery disease	0.000636	0.00288	CcSEcCtD
Fospropofol—Paraesthesia—Enalapril—coronary artery disease	0.000636	0.00288	CcSEcCtD
Fospropofol—Hypotension—Captopril—coronary artery disease	0.000635	0.00288	CcSEcCtD
Fospropofol—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000631	0.00286	CcSEcCtD
Fospropofol—Nervous system disorder—Furosemide—coronary artery disease	0.000629	0.00285	CcSEcCtD
Fospropofol—Pruritus—Fenofibrate—coronary artery disease	0.000627	0.00284	CcSEcCtD
Fospropofol—Paraesthesia—Telmisartan—coronary artery disease	0.000627	0.00284	CcSEcCtD
Fospropofol—Pain—Pravastatin—coronary artery disease	0.000626	0.00284	CcSEcCtD
Fospropofol—Skin disorder—Furosemide—coronary artery disease	0.000623	0.00282	CcSEcCtD
Fospropofol—Pruritus—Clopidogrel—coronary artery disease	0.000617	0.00279	CcSEcCtD
Fospropofol—Hypotension—Perindopril—coronary artery disease	0.000616	0.00279	CcSEcCtD
Fospropofol—Angiopathy—Lisinopril—coronary artery disease	0.000614	0.00278	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000614	0.00278	CcSEcCtD
Fospropofol—Pruritus—Lovastatin—coronary artery disease	0.000612	0.00278	CcSEcCtD
Fospropofol—Mediastinal disorder—Lisinopril—coronary artery disease	0.00061	0.00276	CcSEcCtD
Fospropofol—Paraesthesia—Captopril—coronary artery disease	0.00061	0.00276	CcSEcCtD
Fospropofol—Nausea—Rosuvastatin—coronary artery disease	0.000607	0.00275	CcSEcCtD
Fospropofol—Nervous system disorder—Losartan—coronary artery disease	0.000607	0.00275	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000603	0.00273	CcSEcCtD
Fospropofol—Pruritus—Ezetimibe—coronary artery disease	0.000601	0.00272	CcSEcCtD
Fospropofol—Hypotension—Furosemide—coronary artery disease	0.000599	0.00271	CcSEcCtD
Fospropofol—Pain—Telmisartan—coronary artery disease	0.000597	0.00271	CcSEcCtD
Fospropofol—Paraesthesia—Perindopril—coronary artery disease	0.000592	0.00268	CcSEcCtD
Fospropofol—Nausea—Acetylsalicylic acid—coronary artery disease	0.000589	0.00267	CcSEcCtD
Fospropofol—Pruritus—Eplerenone—coronary artery disease	0.000588	0.00266	CcSEcCtD
Fospropofol—Hypotension—Losartan—coronary artery disease	0.000578	0.00262	CcSEcCtD
Fospropofol—Paraesthesia—Furosemide—coronary artery disease	0.000576	0.00261	CcSEcCtD
Fospropofol—Pruritus—Simvastatin—coronary artery disease	0.000573	0.0026	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000569	0.00258	CcSEcCtD
Fospropofol—Cough—Ramipril—coronary artery disease	0.000567	0.00257	CcSEcCtD
Fospropofol—Pain—Perindopril—coronary artery disease	0.000564	0.00256	CcSEcCtD
Fospropofol—Vomiting—Fenofibrate—coronary artery disease	0.000564	0.00255	CcSEcCtD
Fospropofol—Headache—Fenofibrate—coronary artery disease	0.000555	0.00252	CcSEcCtD
Fospropofol—Paraesthesia—Losartan—coronary artery disease	0.000555	0.00252	CcSEcCtD
Fospropofol—Cough—Timolol—coronary artery disease	0.000554	0.00251	CcSEcCtD
Fospropofol—Vomiting—Clopidogrel—coronary artery disease	0.000554	0.00251	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000553	0.00251	CcSEcCtD
Fospropofol—Vomiting—Lovastatin—coronary artery disease	0.00055	0.00249	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000549	0.00249	CcSEcCtD
Fospropofol—Pain—Furosemide—coronary artery disease	0.000548	0.00248	CcSEcCtD
Fospropofol—Headache—Clopidogrel—coronary artery disease	0.000546	0.00247	CcSEcCtD
Fospropofol—Headache—Lovastatin—coronary artery disease	0.000542	0.00246	CcSEcCtD
Fospropofol—Pruritus—Valsartan—coronary artery disease	0.000541	0.00245	CcSEcCtD
Fospropofol—Vomiting—Ezetimibe—coronary artery disease	0.00054	0.00245	CcSEcCtD
Fospropofol—Pruritus—Olmesartan—coronary artery disease	0.000538	0.00244	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000537	0.00243	CcSEcCtD
Fospropofol—Headache—Ezetimibe—coronary artery disease	0.000532	0.00241	CcSEcCtD
Fospropofol—Pain—Losartan—coronary artery disease	0.000529	0.0024	CcSEcCtD
Fospropofol—Vomiting—Eplerenone—coronary artery disease	0.000528	0.00239	CcSEcCtD
Fospropofol—Nausea—Fenofibrate—coronary artery disease	0.000527	0.00239	CcSEcCtD
Fospropofol—Pruritus—Niacin—coronary artery disease	0.000526	0.00238	CcSEcCtD
Fospropofol—Headache—Eplerenone—coronary artery disease	0.000521	0.00236	CcSEcCtD
Fospropofol—Nervous system disorder—Ramipril—coronary artery disease	0.00052	0.00236	CcSEcCtD
Fospropofol—Pruritus—Pravastatin—coronary artery disease	0.000518	0.00235	CcSEcCtD
Fospropofol—Nausea—Clopidogrel—coronary artery disease	0.000518	0.00235	CcSEcCtD
Fospropofol—Skin disorder—Ramipril—coronary artery disease	0.000515	0.00233	CcSEcCtD
Fospropofol—Vomiting—Simvastatin—coronary artery disease	0.000515	0.00233	CcSEcCtD
Fospropofol—Cough—Lisinopril—coronary artery disease	0.000514	0.00233	CcSEcCtD
Fospropofol—Nausea—Lovastatin—coronary artery disease	0.000514	0.00233	CcSEcCtD
Fospropofol—Nervous system disorder—Timolol—coronary artery disease	0.000508	0.0023	CcSEcCtD
Fospropofol—Headache—Simvastatin—coronary artery disease	0.000507	0.0023	CcSEcCtD
Fospropofol—Nausea—Ezetimibe—coronary artery disease	0.000504	0.00229	CcSEcCtD
Fospropofol—Skin disorder—Timolol—coronary artery disease	0.000504	0.00228	CcSEcCtD
Fospropofol—Pruritus—Trandolapril—coronary artery disease	0.000503	0.00228	CcSEcCtD
Fospropofol—Pruritus—Enalapril—coronary artery disease	0.000501	0.00227	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000498	0.00226	CcSEcCtD
Fospropofol—Hypotension—Ramipril—coronary artery disease	0.000496	0.00225	CcSEcCtD
Fospropofol—Pruritus—Telmisartan—coronary artery disease	0.000494	0.00224	CcSEcCtD
Fospropofol—Nausea—Eplerenone—coronary artery disease	0.000494	0.00224	CcSEcCtD
Fospropofol—Vomiting—Valsartan—coronary artery disease	0.000486	0.0022	CcSEcCtD
Fospropofol—Hypotension—Timolol—coronary artery disease	0.000484	0.0022	CcSEcCtD
Fospropofol—Vomiting—Olmesartan—coronary artery disease	0.000484	0.00219	CcSEcCtD
Fospropofol—Nausea—Simvastatin—coronary artery disease	0.000481	0.00218	CcSEcCtD
Fospropofol—Pruritus—Captopril—coronary artery disease	0.00048	0.00218	CcSEcCtD
Fospropofol—Headache—Valsartan—coronary artery disease	0.000479	0.00217	CcSEcCtD
Fospropofol—Headache—Olmesartan—coronary artery disease	0.000477	0.00216	CcSEcCtD
Fospropofol—Paraesthesia—Ramipril—coronary artery disease	0.000476	0.00216	CcSEcCtD
Fospropofol—Vomiting—Niacin—coronary artery disease	0.000473	0.00214	CcSEcCtD
Fospropofol—Skin disorder—Lisinopril—coronary artery disease	0.000467	0.00212	CcSEcCtD
Fospropofol—Pruritus—Perindopril—coronary artery disease	0.000466	0.00211	CcSEcCtD
Fospropofol—Headache—Niacin—coronary artery disease	0.000466	0.00211	CcSEcCtD
Fospropofol—Paraesthesia—Timolol—coronary artery disease	0.000466	0.00211	CcSEcCtD
Fospropofol—Vomiting—Pravastatin—coronary artery disease	0.000465	0.00211	CcSEcCtD
Fospropofol—Headache—Pravastatin—coronary artery disease	0.000459	0.00208	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000458	0.00207	CcSEcCtD
Fospropofol—Nausea—Valsartan—coronary artery disease	0.000454	0.00206	CcSEcCtD
Fospropofol—Pruritus—Furosemide—coronary artery disease	0.000453	0.00206	CcSEcCtD
Fospropofol—Nausea—Olmesartan—coronary artery disease	0.000452	0.00205	CcSEcCtD
Fospropofol—Vomiting—Trandolapril—coronary artery disease	0.000452	0.00205	CcSEcCtD
Fospropofol—Vomiting—Enalapril—coronary artery disease	0.00045	0.00204	CcSEcCtD
Fospropofol—Hypotension—Lisinopril—coronary artery disease	0.000449	0.00204	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Timolol—coronary artery disease	0.000448	0.00203	CcSEcCtD
Fospropofol—Headache—Trandolapril—coronary artery disease	0.000445	0.00202	CcSEcCtD
Fospropofol—Vomiting—Telmisartan—coronary artery disease	0.000444	0.00201	CcSEcCtD
Fospropofol—Headache—Enalapril—coronary artery disease	0.000444	0.00201	CcSEcCtD
Fospropofol—Pain—Timolol—coronary artery disease	0.000443	0.00201	CcSEcCtD
Fospropofol—Nausea—Niacin—coronary artery disease	0.000442	0.002	CcSEcCtD
Fospropofol—Pruritus—Losartan—coronary artery disease	0.000438	0.00198	CcSEcCtD
Fospropofol—Headache—Telmisartan—coronary artery disease	0.000438	0.00198	CcSEcCtD
Fospropofol—Nausea—Pravastatin—coronary artery disease	0.000435	0.00197	CcSEcCtD
Fospropofol—Paraesthesia—Lisinopril—coronary artery disease	0.000432	0.00196	CcSEcCtD
Fospropofol—Vomiting—Captopril—coronary artery disease	0.000432	0.00196	CcSEcCtD
Fospropofol—Headache—Captopril—coronary artery disease	0.000425	0.00193	CcSEcCtD
Fospropofol—Nausea—Trandolapril—coronary artery disease	0.000422	0.00191	CcSEcCtD
Fospropofol—Nausea—Enalapril—coronary artery disease	0.000421	0.00191	CcSEcCtD
Fospropofol—Vomiting—Perindopril—coronary artery disease	0.000419	0.0019	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000415	0.00188	CcSEcCtD
Fospropofol—Nausea—Telmisartan—coronary artery disease	0.000415	0.00188	CcSEcCtD
Fospropofol—Headache—Perindopril—coronary artery disease	0.000413	0.00187	CcSEcCtD
Fospropofol—Pain—Lisinopril—coronary artery disease	0.000411	0.00186	CcSEcCtD
Fospropofol—Vomiting—Furosemide—coronary artery disease	0.000408	0.00185	CcSEcCtD
Fospropofol—Nausea—Captopril—coronary artery disease	0.000403	0.00183	CcSEcCtD
Fospropofol—Headache—Furosemide—coronary artery disease	0.000402	0.00182	CcSEcCtD
Fospropofol—Vomiting—Losartan—coronary artery disease	0.000393	0.00178	CcSEcCtD
Fospropofol—Nausea—Perindopril—coronary artery disease	0.000392	0.00177	CcSEcCtD
Fospropofol—Headache—Losartan—coronary artery disease	0.000387	0.00176	CcSEcCtD
Fospropofol—Nausea—Furosemide—coronary artery disease	0.000381	0.00173	CcSEcCtD
Fospropofol—Pruritus—Ramipril—coronary artery disease	0.000375	0.0017	CcSEcCtD
Fospropofol—Nausea—Losartan—coronary artery disease	0.000367	0.00166	CcSEcCtD
Fospropofol—Pruritus—Timolol—coronary artery disease	0.000367	0.00166	CcSEcCtD
Fospropofol—Pruritus—Lisinopril—coronary artery disease	0.00034	0.00154	CcSEcCtD
Fospropofol—Vomiting—Ramipril—coronary artery disease	0.000337	0.00153	CcSEcCtD
Fospropofol—Headache—Ramipril—coronary artery disease	0.000332	0.00151	CcSEcCtD
Fospropofol—Vomiting—Timolol—coronary artery disease	0.00033	0.00149	CcSEcCtD
Fospropofol—Headache—Timolol—coronary artery disease	0.000325	0.00147	CcSEcCtD
Fospropofol—Nausea—Ramipril—coronary artery disease	0.000315	0.00143	CcSEcCtD
Fospropofol—Nausea—Timolol—coronary artery disease	0.000308	0.0014	CcSEcCtD
Fospropofol—Vomiting—Lisinopril—coronary artery disease	0.000306	0.00139	CcSEcCtD
Fospropofol—Headache—Lisinopril—coronary artery disease	0.000301	0.00137	CcSEcCtD
Fospropofol—Nausea—Lisinopril—coronary artery disease	0.000286	0.00129	CcSEcCtD
Fospropofol—GABRG3—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.45e-05	0.000177	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—APOB—coronary artery disease	3.44e-05	0.000177	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HK1—coronary artery disease	3.42e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCG5—coronary artery disease	3.42e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	3.42e-05	0.000176	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—APOB—coronary artery disease	3.42e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CD36—coronary artery disease	3.41e-05	0.000176	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPAP2B—coronary artery disease	3.41e-05	0.000175	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CKM—coronary artery disease	3.41e-05	0.000175	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UQCRFS1—coronary artery disease	3.41e-05	0.000175	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SELE—coronary artery disease	3.4e-05	0.000175	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.4e-05	0.000175	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.36e-05	0.000173	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—coronary artery disease	3.36e-05	0.000173	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—APOB—coronary artery disease	3.36e-05	0.000173	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	3.33e-05	0.000171	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—PLG—coronary artery disease	3.32e-05	0.000171	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PRKCD—coronary artery disease	3.31e-05	0.00017	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.3e-05	0.00017	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ALDOA—coronary artery disease	3.3e-05	0.00017	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	3.27e-05	0.000168	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.25e-05	0.000167	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.22e-05	0.000166	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—coronary artery disease	3.22e-05	0.000165	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.21e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	3.21e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—coronary artery disease	3.2e-05	0.000165	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PDK4—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PYGM—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT4A1—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CKMT2—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDH6A1—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.17e-05	0.000163	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—MAPK1—coronary artery disease	3.15e-05	0.000162	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—MAPK1—coronary artery disease	3.1e-05	0.00016	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CRK—coronary artery disease	3.07e-05	0.000158	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.06e-05	0.000157	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SH2B3—coronary artery disease	3.03e-05	0.000156	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VWF—coronary artery disease	3.03e-05	0.000156	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ATP2A2—coronary artery disease	3.03e-05	0.000156	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—APOA1—coronary artery disease	2.98e-05	0.000153	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—coronary artery disease	2.97e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—coronary artery disease	2.96e-05	0.000152	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—MAPK1—coronary artery disease	2.94e-05	0.000151	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—APOB—coronary artery disease	2.93e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK14—coronary artery disease	2.93e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—coronary artery disease	2.91e-05	0.00015	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.9e-05	0.000149	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—MAPK1—coronary artery disease	2.9e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SPARC—coronary artery disease	2.89e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—F2R—coronary artery disease	2.89e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—F7—coronary artery disease	2.89e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—F2—coronary artery disease	2.84e-05	0.000146	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—FN1—coronary artery disease	2.84e-05	0.000146	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IRF1—coronary artery disease	2.83e-05	0.000146	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FGB—coronary artery disease	2.83e-05	0.000146	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMGCS2—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GATM—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PFKM—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LDHA—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GYG1—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GK—coronary artery disease	2.83e-05	0.000145	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.82e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB2—coronary artery disease	2.78e-05	0.000143	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.77e-05	0.000142	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	2.77e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	2.76e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	2.76e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	2.76e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—THBS1—coronary artery disease	2.76e-05	0.000142	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	2.75e-05	0.000141	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.73e-05	0.000141	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	2.73e-05	0.00014	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.72e-05	0.00014	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.7e-05	0.000139	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AK1—coronary artery disease	2.7e-05	0.000139	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCH1—coronary artery disease	2.7e-05	0.000139	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.69e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	2.67e-05	0.000137	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.65e-05	0.000137	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MAPK1—coronary artery disease	2.65e-05	0.000136	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	2.64e-05	0.000136	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	2.63e-05	0.000135	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—coronary artery disease	2.59e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MDH2—coronary artery disease	2.59e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLCD1—coronary artery disease	2.59e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UGCG—coronary artery disease	2.59e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPAT—coronary artery disease	2.59e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TIMP1—coronary artery disease	2.58e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAT—coronary artery disease	2.58e-05	0.000133	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MAPK1—coronary artery disease	2.58e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	2.56e-05	0.000132	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—coronary artery disease	2.55e-05	0.000131	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	2.53e-05	0.00013	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MAPK1—coronary artery disease	2.53e-05	0.00013	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—coronary artery disease	2.51e-05	0.000129	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PGM1—coronary artery disease	2.49e-05	0.000128	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	2.49e-05	0.000128	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MAPK1—coronary artery disease	2.49e-05	0.000128	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MAPK1—coronary artery disease	2.47e-05	0.000127	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	2.43e-05	0.000125	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MAPK1—coronary artery disease	2.43e-05	0.000125	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	2.41e-05	0.000124	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CKB—coronary artery disease	2.4e-05	0.000124	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PYGB—coronary artery disease	2.4e-05	0.000124	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	2.4e-05	0.000124	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	2.36e-05	0.000122	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	2.35e-05	0.000121	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.32e-05	0.000119	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.3e-05	0.000118	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGAV—coronary artery disease	2.27e-05	0.000117	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KNG1—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—COX5B—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PFKFB3—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLIN1—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM2—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—DLAT—coronary artery disease	2.26e-05	0.000116	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAUR—coronary artery disease	2.24e-05	0.000115	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—coronary artery disease	2.23e-05	0.000115	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	2.23e-05	0.000115	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA2—coronary artery disease	2.22e-05	0.000114	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLG—coronary artery disease	2.19e-05	0.000113	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.19e-05	0.000113	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	2.19e-05	0.000113	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.16e-05	0.000111	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.15e-05	0.000111	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT1E1—coronary artery disease	2.14e-05	0.00011	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.14e-05	0.00011	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MAPK1—coronary artery disease	2.12e-05	0.000109	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCE—coronary artery disease	2.11e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SOD1—coronary artery disease	2.1e-05	0.000108	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.1e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.08e-05	0.000107	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKR1B1—coronary artery disease	2.04e-05	0.000105	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HK2—coronary artery disease	2.04e-05	0.000105	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC27A1—coronary artery disease	1.96e-05	0.000101	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—APOB—coronary artery disease	1.94e-05	9.98e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LCAT—coronary artery disease	1.92e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CPT1B—coronary artery disease	1.92e-05	9.88e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	1.9e-05	9.77e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HGF—coronary artery disease	1.89e-05	9.7e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOA4—coronary artery disease	1.89e-05	9.7e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CSF2—coronary artery disease	1.87e-05	9.6e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.85e-05	9.53e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.84e-05	9.46e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PDHA1—coronary artery disease	1.82e-05	9.37e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCLM—coronary artery disease	1.82e-05	9.37e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGB3—coronary artery disease	1.79e-05	9.2e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.77e-05	9.08e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TXNRD1—coronary artery disease	1.76e-05	9.07e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP11B2—coronary artery disease	1.76e-05	9.07e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CD36—coronary artery disease	1.76e-05	9.05e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.75e-05	9.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC22A3—coronary artery disease	1.74e-05	8.94e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PPP2CA—coronary artery disease	1.74e-05	8.94e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ARNTL—coronary artery disease	1.71e-05	8.81e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HADH—coronary artery disease	1.71e-05	8.81e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCD—coronary artery disease	1.71e-05	8.78e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.69e-05	8.67e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	1.68e-05	8.64e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.64e-05	8.46e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	1.63e-05	8.36e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLA2G2A—coronary artery disease	1.62e-05	8.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOA2—coronary artery disease	1.62e-05	8.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX2—coronary artery disease	1.62e-05	8.35e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MMP1—coronary artery disease	1.6e-05	8.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCG5—coronary artery disease	1.6e-05	8.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT1A1—coronary artery disease	1.6e-05	8.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HK1—coronary artery disease	1.6e-05	8.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX4—coronary artery disease	1.6e-05	8.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.6e-05	8.24e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HADHA—coronary artery disease	1.58e-05	8.15e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—coronary artery disease	1.57e-05	8.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTA1—coronary artery disease	1.57e-05	8.06e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LPA—coronary artery disease	1.55e-05	7.97e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—APOA1—coronary artery disease	1.53e-05	7.89e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK14—coronary artery disease	1.51e-05	7.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLCB3—coronary artery disease	1.5e-05	7.72e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	1.49e-05	7.67e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOA5—coronary artery disease	1.48e-05	7.64e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—F2—coronary artery disease	1.46e-05	7.53e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FN1—coronary artery disease	1.46e-05	7.53e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	1.46e-05	7.53e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—P4HB—coronary artery disease	1.46e-05	7.49e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS2—coronary artery disease	1.45e-05	7.44e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.44e-05	7.42e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLA2G1B—coronary artery disease	1.43e-05	7.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.41e-05	7.27e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.4e-05	7.19e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—VCAN—coronary artery disease	1.35e-05	6.93e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDOA—coronary artery disease	1.34e-05	6.88e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.33e-05	6.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—DCN—coronary artery disease	1.3e-05	6.68e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF1—coronary artery disease	1.28e-05	6.6e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.27e-05	6.53e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDH2—coronary artery disease	1.26e-05	6.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.23e-05	6.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LIPC—coronary artery disease	1.23e-05	6.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HBA1—coronary artery disease	1.23e-05	6.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2C19—coronary artery disease	1.23e-05	6.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3C2A—coronary artery disease	1.23e-05	6.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOC3—coronary artery disease	1.22e-05	6.29e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINE1—coronary artery disease	1.22e-05	6.27e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LDLR—coronary artery disease	1.22e-05	6.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.21e-05	6.24e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—coronary artery disease	1.2e-05	6.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC9A1—coronary artery disease	1.2e-05	6.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCLC—coronary artery disease	1.19e-05	6.11e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CETP—coronary artery disease	1.19e-05	6.11e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SDC1—coronary artery disease	1.17e-05	6.04e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS3—coronary artery disease	1.16e-05	5.98e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—JAK2—coronary artery disease	1.13e-05	5.81e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMA6—coronary artery disease	1.11e-05	5.7e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMB5—coronary artery disease	1.11e-05	5.7e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CTGF—coronary artery disease	1.08e-05	5.57e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GOT2—coronary artery disease	1.07e-05	5.52e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMGCR—coronary artery disease	1.07e-05	5.52e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.04e-05	5.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLCB1—coronary artery disease	9.87e-06	5.08e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	9.68e-06	4.98e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCA1—coronary artery disease	9.57e-06	4.92e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GGT1—coronary artery disease	9.27e-06	4.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GOT1—coronary artery disease	9.27e-06	4.77e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—coronary artery disease	8.38e-06	4.31e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—coronary artery disease	8.32e-06	4.28e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARGC1A—coronary artery disease	8.25e-06	4.24e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMOX1—coronary artery disease	8.21e-06	4.22e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CAT—coronary artery disease	8.1e-06	4.17e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOB—coronary artery disease	7.86e-06	4.04e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—coronary artery disease	7.69e-06	3.96e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—coronary artery disease	7.65e-06	3.93e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK1—coronary artery disease	7.54e-06	3.88e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LPL—coronary artery disease	7.51e-06	3.86e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX1—coronary artery disease	7.32e-06	3.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CD36—coronary artery disease	7.13e-06	3.67e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP2CA—coronary artery disease	7.04e-06	3.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—coronary artery disease	6.76e-06	3.48e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—coronary artery disease	6.54e-06	3.37e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AGT—coronary artery disease	6.42e-06	3.3e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOE—coronary artery disease	6.29e-06	3.24e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOA1—coronary artery disease	6.22e-06	3.2e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.96e-06	3.06e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARG—coronary artery disease	5.48e-06	2.82e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—POMC—coronary artery disease	5.41e-06	2.78e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—coronary artery disease	5.35e-06	2.75e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NOS3—coronary artery disease	4.71e-06	2.43e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—coronary artery disease	4.31e-06	2.22e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—coronary artery disease	2.65e-06	1.36e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—coronary artery disease	2.17e-06	1.11e-05	CbGpPWpGaD
